JP Morgan Chase
KITE

JP Morgan Chase’s Kite Pharma, Inc. KITE Stock Holding History

JP Morgan Chase’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,528,805
Closed -$275M – 5737
2017
Q3 		$275M Sell
1,528,805
-838,947
-35% -$117M 0.06% 324
2017
Q2 		$245M Sell
2,367,752
-56,813
-2% -$4.64M 0.06% 342
2017
Q1 		$190M Sell
2,424,565
-570,282
-19% -$35.3M 0.04% 420
2016
Q4 		$134M Buy
2,994,847
+386,871
+15% +$19M 0.03% 493
2016
Q3 		$146M Sell
2,607,976
-560,080
-18% -$31.2M 0.04% 451
2016
Q2 		$158M Buy
3,168,056
+379,661
+14% +$18.7M 0.04% 430
2016
Q1 		$128M Buy
2,788,395
+528,222
+23% +$25.6M 0.03% 486
2015
Q4 		$139M Buy
2,260,173
+730,793
+48% +$51.4M 0.04% 474
2015
Q3 		$85.2M Sell
1,529,380
-160,262
-9% -$10.1M 0.02% 592
2015
Q2 		$103M Buy
1,689,642
+458,209
+37% +$26.1M 0.02% 589
2015
Q1 		$71M Buy
1,231,433
+404,867
+49% +$27.1M 0.02% 753
2014
Q4 		$47.7M Buy
826,566
+74,940
+10% +$3.16M 0.01% 949
2014
Q3 		$21.4M Buy
+751,626
New +$18.6M 0.01% 1401

JP Morgan Chase's KITE Position: Q4 2017 in Review

JP Morgan Chase sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,528,805 shares — an estimated $275M sold.

JP Morgan Chase first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $275M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • JP Morgan Chase reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • JP Morgan Chase sold 1,528,805 Kite Pharma, Inc. shares in Q4 2017, an estimated $275M.
  • JP Morgan Chase first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
  • JP Morgan Chase's Kite Pharma, Inc. position peaked at $275M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.